Differential diagnosis of hypercalcemia

Area of Science:

• Endocrinology
• Internal Medicine
• Biochemistry

Background:

• Hypercalcemia presents a complex differential diagnosis with over 25 potential causes.
• Primary hyperparathyroidism and malignancy are the most common etiologies, accounting for 80-90% of cases.
• Malignancy is more prevalent in hospitalized patients (up to 65%), while primary hyperparathyroidism dominates the ambulatory population.

Purpose of the Study:

• To evaluate the diagnostic utility of various serum and urinary markers in differentiating hypercalcemia causes.
• To identify the most effective and economical methods for diagnosing primary hyperparathyroidism.

Main Methods:

• Review of clinical factors favoring primary hyperparathyroidism.
• Analysis of serum calcium, parathyroid hormone (PTH), chloride, phosphorus, 25-OHD, 1,25-(OH)2D, and urinary calcium.
• Application of multivariate discriminant analysis using serum calcium, phosphorus, chloride, and hematocrit.
• Assessment of PTH assays for diagnostic accuracy.

Main Results:

• Serum PTH, chloride, and calcium are most useful in distinguishing primary hyperparathyroidism from other hypercalcemic conditions.
• Multivariate discriminant analysis (serum calcium, phosphorus, chloride, hematocrit) achieves 95-98% accuracy.
• Adding amino-terminal or intact PTH assays increases diagnostic accuracy to 99%, crucial for renal insufficiency cases.

Conclusions:

• Serum PTH, calcium, and chloride levels provide essential discriminatory value for hypercalcemia.
• Multivariate analysis offers an accurate and cost-effective approach to identifying primary hyperparathyroidism.
• PTH assays are indispensable for definitive diagnosis, especially in patients with impaired kidney function.